Iovance Biotherapeutics, Inc. (IOVA)
2.35
-0.05
(-2.08%)
USD |
NASDAQ |
Jan 13, 16:00
2.32
-0.03
(-1.28%)
Pre-Market: 09:08
Iovance Biotherapeutics Research and Development Expense (Quarterly): 75.17M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 2.436M |
| Intellia Therapeutics, Inc. | 92.33M |
| Perspective Therapeutics, Inc. | 19.56M |
| Electromed, Inc. | 0.241M |
| InfuSystem Holdings, Inc. | -- |